https://www.optimumcomms.com/wp-content/uploads/2024/09/iOnctura_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2025-03-17 09:14:332025-03-25 14:23:15iOnctura strengthens leadership with appointments of Chief Business Officer and Board Chair
https://www.optimumcomms.com/wp-content/uploads/2024/09/iOnctura_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2025-03-17 09:14:332025-03-25 14:23:15iOnctura strengthens leadership with appointments of Chief Business Officer and Board Chair
https://www.optimumcomms.com/wp-content/uploads/2023/10/splicebio-1.png
1000
1000
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2025-03-13 11:18:192025-03-25 14:32:30SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
https://www.optimumcomms.com/wp-content/uploads/2024/03/Heidelberg_Logo_300x180px-80x80Web_Logos-1.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2025-03-13 08:39:512025-03-25 14:24:55Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
https://www.optimumcomms.com/wp-content/uploads/2023/06/NovoFund_Logo_300x180px-80x80-1.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2025-03-13 08:28:412025-03-25 14:30:17Pioneering plant microbiome research: Julia Vorholt receives 2025 Novonesis Biotechnology Prize from the Novo Nordisk Foundation
https://www.optimumcomms.com/wp-content/uploads/2024/04/Xeltis_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2025-03-11 08:48:542025-03-25 14:26:01Xeltis expands Medical Advisory Board with World Leading Experts in Clinical Nephrology
https://www.optimumcomms.com/wp-content/uploads/2023/02/Sofinnova_Logo_300-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-03-04 07:09:382025-03-04 07:09:38Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
https://www.optimumcomms.com/wp-content/uploads/2023/02/Biocomposites_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-03-03 08:44:492025-03-03 09:14:54Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth
https://www.optimumcomms.com/wp-content/uploads/2025/02/Domain_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-27 08:55:282025-02-27 08:55:28Domain Therapeutics to present and participate at major global healthcare conferences, March to June 2025
https://www.optimumcomms.com/wp-content/uploads/2023/02/ViCentra_Logo_300x180px-3.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-26 08:30:202025-02-26 08:30:20Experienced Industry Leader Tom Arnold Appointed as Chief Executive Officer of ViCentra
https://www.optimumcomms.com/wp-content/uploads/2024/10/Ottimo_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-25 13:01:032025-02-25 13:01:03Ottimo Pharma Strengthens Leadership Team with Senior Appointments
https://www.optimumcomms.com/wp-content/uploads/2023/06/NovoFund_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-24 10:23:272025-02-24 10:23:27Unravelling the infection enigma: Jean-Laurent Casanova’s pioneering genetic discoveries earn him the 2025 Novo Nordisk Prize
https://www.optimumcomms.com/wp-content/uploads/2025/01/Ona_Therapeutics_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-19 08:31:082025-02-19 08:31:08Ona Therapeutics Strengthens Leadership Team to Accelerate First-in-Class ADCs into Clinical Development Across Cancer Types
https://www.optimumcomms.com/wp-content/uploads/2024/10/Loqus23_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-18 08:39:012025-02-18 08:39:01LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
https://www.optimumcomms.com/wp-content/uploads/2023/06/NovoFund_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-12 11:04:582025-02-12 11:04:58Philanthropic Partnership Launches New Initiative Tackling Antimicrobial Resistance, the Third-Leading Cause of Death Globally, By Fast-Tracking Discovery of New Treatments
https://www.optimumcomms.com/wp-content/uploads/2023/02/Ariceum_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-06 08:39:362025-02-06 08:39:36U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics’ Proprietary Radiopharmaceutical Cancer Therapy
https://www.optimumcomms.com/wp-content/uploads/2025/02/Liva_Logo_300x180px-80x80Web_Logos.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2025-02-05 08:40:552025-02-05 09:57:59Liva Healthcare acquires Momenta, and secures funding from new and existing investors to drive growthWe’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
